Global Vascular Grafts Industry: Key Statistics and Insights in 2025-2033

Summary:

• The global vascular grafts market size reached USD 2.0 Billion in 2024.
• The market is expected to reach USD 3.3 Billion by 2033, exhibiting a growth rate (CAGR) of 5.42% during 2025-2033.
• North America leads the market, accounting for the largest vascular grafts market share.
• Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.
• Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.
• The ongoing technological advancements in graft materials and design are supporting the market growth.
• The rising shift towards minimally invasive surgeries (MIS) is propelling the market growth.

Industry Trends and Drivers:

• Prevalence of Cardiovascular Diseases:

The growth of this sector is driven by the rising global incidence of cardiovascular diseases (CVD), which typically require operations using vascular grafts.

• Technological Advancements in Graft Materials and Design:

The market has boomed due to dedicated improvements in graft related products. The current generation vascular grafts are non-thrombogenic, non-immunogenic and long lasting and have minimal adverse effects such as infection and rejection. Drug eluting and tissue engineered grafts are also coming up. These grafts should be less rejected by the body, compared to the currently used grafts which are more mechanical in their properties. They are also used to improve vascular surgery and thus improve the experience of patients.

• Preference for Minimally Invasive Surgeries (MIS):

The growth of the market is fueled by minimally invasive surgery (MIS). Minimally invasive surgical treatments include endovascular aneurysm repair (EVAR) and thoracic endovascular aneurysm repair (TEVAR). They also reduce the number of hospitalizations, reduce the chances of morbidity and speed up the healing process. This is what drives interest in the specific vascular grafts required for these surgeries. In addition, there has been a shift in the patient-physician relationship towards MIS (Forrest and Taylor (2006)). This trend increases the need for evenly aligned vascular grafts.

Request for a sample copy of this report: https://www.imarcgroup.com/vascular-grafts-market/requestsample

Vascular Grafts Market Report Segmentation:

By Product:

• Endovascular Stent Grafts
• Hemodialysis Access Grafts
• Coronary Artery By-Pass Grafts
• Vascular Grafts for Aorta Disease
• Peripheral Vascular Grafts

Endovascular stent grafts represent the largest segment as they are increasingly preferred for minimally invasive (MI) vascular procedures due to their efficacy and lower invasiveness.

By Raw Material:

• Polytetrafluoroethylene (PTFE)
• Polyester
• Polyurethane
• Biosynthetic

Polytetrafluoroethylene (PTFE) holds the biggest market share, attributed to its widespread use in vascular graft manufacturing, owing to its biocompatibility and durability.

By Application:

• Cardiac Aneurysm
• Kidney Failure
• Vascular Occlusion
• Coronary Artery Disease

Cardiac aneurysm exhibits a clear dominance in the market due to the rising incidence of cardiac aneurysms, necessitating vascular grafts for treatment.

By End User:

• Hospitals
• Ambulatory Surgical Centers (ASCs)

Hospitals account for the majority of the market share as they are the primary healthcare facilities where vascular graft procedures are conducted.

Regional Insights:

• North America (United States, Canada)
• Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa

North America dominates the market, which can be accredited to the increasing adoption of advanced vascular graft technologies and a rising prevalence of vascular diseases in the region.

Top Vascular Grafts Market Leaders: 

The vascular grafts market research report outlines a detailed analysis of the competitive landscape, offering in-depth profiles of major companies. Some of the key players in the market are:

• Abbott Laboratories
• B. Braun SE (B. Braun Holding GmbH & Co. KG)
• Becton, Dickinson & Company
• Cook Group Incorporated
• Cordis
• CryoLife Inc.
• Getinge AB
• Heat Medical Europe BV
• LeMaitre Vascular
• Medtronic plc
• Terumo Corporation
• W.L. Gore & Associates Inc.

Note: If you require any specific information that is not covered currently within the scope of the report, we will provide the same as a part of the customization.

About Us:

IMARC Group is a global management consulting firm that helps the world’s most ambitious changemakers to create a lasting impact. The company provide a comprehensive suite of market entry and expansion services. IMARC offerings include thorough market assessment, feasibility studies, company incorporation assistance, factory setup support, regulatory approvals and licensing navigation, branding, marketing and sales strategies, competitive landscape and benchmarking analyses, pricing and cost research, and procurement research.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145